Genome editing and its role in vaccine, diagnosis, and therapeutic advancement

Deepanker Bisht,Sagar Salave,Nimeet Desai,Purnima Gogoi,Dhwani Rana,Prachurya Biswal,Gautami Sarma,Derajram Benival,Nagavendra Kommineni,Dhruv Desai
DOI: https://doi.org/10.1016/j.ijbiomac.2024.131802
IF: 8.2
2024-05-08
International Journal of Biological Macromolecules
Abstract:Genome editing involves precise modification of specific nucleotides in the genome using nucleases like CRISPR/Cas, ZFN, or TALEN, leading to increased efficiency of homologous recombination (HR) for gene editing, and it can result in gene disruption events via non-homologous end joining (NHEJ) or homology-driven repair (HDR). Genome editing, particularly CRISPR-Cas9, revolutionizes vaccine development by enabling precise modifications of pathogen genomes, leading to enhanced vaccine efficacy and safety. It allows for tailored antigen optimization, improved vector design, and deeper insights into host genes' impact on vaccine responses, ultimately enhancing vaccine development and manufacturing processes. This review highlights different types of genome editing methods, their associated risks, approaches to overcome the shortcomings, and the diverse roles of genome editing.
polymer science,biochemistry & molecular biology,chemistry, applied
What problem does this paper attempt to address?